₹ 991.00
-6.90 (-0.69%)Open
1014.95High
1014.95Low
986Prev Close
997.9P/E
32.98Median P/E
30.61P/B
4.45Median P/B
4.51Market Cap
194.79BPEG
1.49Div.Yield
0.81Bid
-Ask
-Large Cap
194.79B Mkt. Cap.Volatility
-Beta
0.63Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 945.72 | 949.02 |
10 | 966.95 | 968.55 |
20 | 976.38 | 977.94 |
50 | 989.69 | 990.60 |
100 | 909.79 | 910.30 |
300 | 828.21 | 828.58 |
BSE
533573NSE
APLLTDISIN
INE901L01018Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.
Chirayu Amin
Executive Chairman of the Board, Chief Executive OfficerRaj Baheti
Chief Financial Officer, Director - Finance, Executive DirectorManisha Saraf
Compliance Officer, Company SecretaryPranav Amin
Managing Director, Executive DirectorShaunak Amin
Managing Director, Executive Director